Search
forLearn
5 / 801 resultslearn Setipiprant
learn Arjun
learn Bhringraj
learn Haritaki
Research
5 / 1000+ results
research STUDY ON KESHA SHAREERA W.S.R TO KHALITYA (MALE PATTERN BALDNESS) IN RELATION WITH DAIHIKA PRAKRUTI.
Certain Prakruti types are more prone to early male pattern baldness.
research Hair Medulla and its variations in Doshaja Prakruti – An observational study
Hair medulla patterns vary by Prakruti type, affecting hair strength.
research Risk Factors Affecting Khalitya (Hair Fall) As Per Deha Prakruti- A Case Control Study Among Adults
Age, stress, and anger increase the risk of hair fall.
research A review of Kesha as diagnostic and prognostic tool in Ayurveda
Hair can indicate health issues and help diagnose and treat conditions in Ayurveda.
research Review of Ayurvedic herbs with Kesharanjana Property in the Management of Caniites (Palitya)
Certain Ayurvedic herbs may help manage premature greying of hair.
Community Join
5 / 1000+ resultscommunity Kintor KX -826 Pyrilutamide Adds 1 Year Phase 3 Trial For Safety
KX-826/pyrilutamide is undergoing an additional one-year safety and efficacy trial in China after a six-month study. Some participants speculate on the reasons for the extended trial and discuss the potential of other treatments.
community Will kintor show pyrilutamide phase 3 trials result this q
The conversation is about the release of a new phase 3 clinical trial for a year and questioning if the results of the 6-month clinical trials will be shown this quarter. The specific treatment discussed is Pyrilutamide.
community Pyrilutamide KX826 Legit Source???
Pyrilutamide (KX826) sourcing and pricing, with users discussing the legitimacy and cost of grey market versus official sources. The conversation highlights the high cost of official products and the effectiveness of grey market versions.
community How far along is Kintor in its Phase II U.S. trials for pyrilutamide?
Kintor's Phase II U.S. trials for pyrilutamide and the process of pharmaceutical drugs coming to market, with a reply from someone who has just ordered 500mg of Pyrilutamide to start their own phase trials.
community Kintor has released an investor relations memo regarding Chinese Phase III trials for Pyrilutamide
Kintor's Pyrilutamide (KX-826) showed hair growth in Chinese Phase III trials but did not significantly outperform placebo. The treatment was safe with no major adverse reactions reported.